Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Gemifloxacin Mesylate Tablets
- Product Name
- 吉速星
- Approval Number
- 国药准字HJ20170329
- Approval Date
- Oct 10, 2023
NMPA
Gemifloxacin Mesylate Tablets
- Product Name
- 吉速星
- Approval Number
- 国药准字HJ20170326
- Approval Date
- Oct 10, 2023
NMPA
BDDE-Crosslinked Sodium Hyaluronate Injection
- Product Name
- 丁甘交联玻璃酸钠注射液
- Approval Number
- 国药准字HJ20233147
- Approval Date
- Mar 28, 2023
NMPA
Recombinant Human Growth Hormone for Injection
- Product Name
- 尤得盼
- Approval Number
- 国药准字SJ20181002
- Approval Date
- Nov 17, 2022
NMPA
Recombinant Human Growth Hormone for Injection
- Product Name
- 尤得盼
- Approval Number
- 国药准字SJ20181003
- Approval Date
- Nov 17, 2022
NMPA
Recombinant Human Follitropin Prefilled Syringe
- Product Name
- 芳乐舒
- Approval Number
- 国药准字SJ20210005
- Approval Date
- Apr 7, 2021
NMPA
Recombinant Human Follitropin Prefilled Syringe
- Product Name
- 芳乐舒
- Approval Number
- 国药准字SJ20210008
- Approval Date
- Apr 7, 2021
NMPA
Recombinant Human Follitropin Prefilled Syringe
- Product Name
- 芳乐舒
- Approval Number
- 国药准字SJ20210006
- Approval Date
- Apr 7, 2021
NMPA
Recombinant Human Follitropin Prefilled Syringe
- Product Name
- 芳乐舒
- Approval Number
- 国药准字SJ20210007
- Approval Date
- Apr 7, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found